Table 1 Demographics and baseline characteristics of patients with COVID-19
No. (%) | P Value a | |||
|---|---|---|---|---|
Total(N = 143) | Mild/Moderate (n = 72) | Severe/Critical(n = 71) | ||
Age, median (IQR), y | 58 (39–67) | 44 (32–60) | 65 (53–69) | 0.000 |
Sex | 0.009 | |||
Female | 70 (49.0) | 43 (59.7) | 27 (38.0) | |
Male | 73 (51.0) | 29 (40.3) | 44 (62.0) | |
Huanan Seafood Wholesale Market exposure | 11 (7.7) | 4 (5.6) | 7 (9.7) | 0.359 |
Comorbidities | 50 (35.0) | 10 (13.9) | 40 (56.3) | 0.000 |
Hypertension | 36 (25.2) | 5 (6.9) | 31 (43.7) | 0.000 |
Cardiovascular disease | 16 (11.2) | 4 (5.6) | 12 (16.9) | 0.031 |
Diabetes | 13 (9.1) | 4 (5.6) | 9 (12.7) | 0.139 |
Chronic obstructive pulmonary disease | 10 (7.0) | 3 (4.2) | 7 (9.9) | 0.091 |
Cerebrovascular disease | 5 (3.5) | 2 (2.8) | 3 (4.2) | 0.987 |
Signs and symptoms | ||||
Fever | 137 (95.8) | 70 (97.2) | 67 (94.4) | 0.619 |
Fatigue | 93 (65.0) | 42 (58.3) | 51 (71.8) | 0.091 |
Dry cough | 78 (54.5) | 37 (51.4) | 41 (57.7) | 0.455 |
Anorexia | 66 (46.2) | 23 (31.9) | 43 (60.6) | 0.001 |
Chest tightness | 63 (44.1) | 29 (40.3) | 34 (47.9) | 0.359 |
Myalgia | 49 (34.3) | 18 (25.0) | 31 (43.7) | 0.019 |
Mild shortness of breath | 48 (33.6) | 33 (45.8) | 15 (21.1) | 0.002 |
Chill | 33 (23.1) | 19 (26.4) | 14 (19.7) | 0.344 |
Dyspnea | 31 (21.7) | 10 (13.9) | 21 (29.6) | 0.023 |
Pharyngalgia | 28 (19.6) | 12 (16.7) | 16 (22.5) | 0.377 |
Diarrhea | 26 (18.2) | 12 (16.7) | 14 (19.7) | 0.636 |
Expectoration | 22 (15.4) | 5 (6.9) | 17 (23.9) | 0.005 |
Nausea or Vomiting | 14 (9.8) | 7 (9.7) | 7 (9.9) | 0.978 |
Headache | 7 (4.9) | 3 (4.2) | 4 (5.6) | 0.985 |
Multiple lung lobe or bilateral involvement | 138 (96.5) | 68 (94.4) | 70 (98.6) | 0.371 |
Onset of symptom to Hospital admission, median (IQR), d | 5 (3–7) | 4 (3–5) | 6 (5–7) | 0.000 |